Stock ALPMY ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Astellas Pharma Inc. OTC Markets

Equities

ALPMY

US04623U1025

Delayed OTC Markets
Other stock markets
 12:41:49 21/06/2024 am IST 		5-day change 1st Jan Change
9.37 USD -1.26% Intraday chart for Astellas Pharma Inc. -2.29% -21.26%
03/06 US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab MT
31/05 U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ASTELLAS PHARMA INC.
Other Pharmaceuticals
-1.26%-2.29%-21.26%-40.24%-32.83% 1.71TCr - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. ALPMY Stock
  5. Charts Astellas Pharma Inc.
  6. Comparison Chart